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Abstract
Most low-income nations have no practice guidelines for brain death; data describing brain death in these regions is
absent. Our retrospective study describes the prevalence of brain death among patients treated in an intensive care unit
(ICU) at a referral hospital in Malawi. The primary outcome was designation of brain death in the medical chart. Of 449
ICU patients included for analysis between September 2016 and May 2018, 43 (9.6%) were diagnosed with brain death
during the ICU admission. The most common diagnostic reasons for admission among these patients were trauma (49%),
malaria (16%) and postoperative monitoring after general abdominal surgery (19%). All patients diagnosed with brain
death were declared dead in the hospital, after cardiac death. In conclusion, the incidence of brain death in a Malawi ICU
is substantially higher than that seen in high-income ICU settings. Brain death is not treated as clinical death in Malawi.
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Introduction
The concept of brain death first emerged in the 1950s,
driven by advances in critical care medicine such as car-
diopulmonary resuscitation and mechanical ventilation.
In countries where it is an accepted concept, a patient
determined to be brain dead is legally and clinically dead
with an irreversible loss of all brain function.1 While the
precise criteria for this diagnosis have changed over time
in the evolving context of critical care medicine and
advanced neurologic diagnostic techniques, they
remain based on a clinical neurological examination.1
Practice guidelines were published by the American
Academy of Neurology in 19952 and updated in 2010.1
Despite these definitions and guidelines, brain death
lacks global acceptance and there are substantial differ-
ences in the application of this diagnosis worldwide.3
Most low-income countries (LIC) have no legal nor
clinical practice guidelines for brain death.3 The reasons
cited for a lack of guidelines by LIC respondents in one
large global survey included: (1) lack of physician expert-
ise; and (2) uncertainties about the concept.3 There is
also sociocultural and/or religious resistance to this con-
cept in many nations.4–6 Diagnosing brain death is a
first step to addressing the futility of further intensive
or invasive care and might influence triage decisions in
low-resource areas. This may be especially relevant in
LICs, where hospital and intensive care unit (ICU)
beds are very scarce. Reframing the concept of brain
death in the context of organ failure may motivate
healthcare providers in LICs to perform a relevant
neurologic examination. Increased identification of
brain death may be disproportionately beneficial to
LIC healthcare systems where specialists in neurology,
neurological surgery and critical care are often absent.
However, prospective research on this topic in low-
income settings is essentially absent. The objective of
our study was to describe the prevalence of brain
death among patients treated in an ICU at a central
referral hospital in Malawi.
Methods
Ours was a retrospective, single-centre observational
study of patients admitted to the ICU of Kamuzu
Central Hospital (KCH), a central referral hospital in
Lilongwe, Malawi, from September 2016 to May 2018.
Malawi is a small landlocked country in southeast
Africa bordered by Zambia, Tanzania and
Mozambique (Figure 1). It is one of the poorest coun-
tries in the world with a life expectancy of 63.8 years
and a Human Development Index rank of 170 out of
187 countries.7
KCH is a 700-bed referral hospital in the central
region of Malawi with a catchment area of approxi-
mately 6 million. It has a computed tomography (CT)
scanner and an ICU with five ventilator-equipped beds.
The ICU offers continuous non-invasive vital sign
monitoring (i.e. no arterial line equipment) and can
provide intravenous vasopressor or sedative infusions.
The nursing ratio is 1:1 and clinical care in the unit is
directed by clinical officers in Anesthesiology.8 No con-
sultant physicians are on staff with expertise in inten-
sive care medicine or neurology. A consultant in
neurological surgery is available, but there is currently
no equipment for intracranial pressure monitoring nor
surgical procedures other than exploratory burr-holes.
The hospital also has four high-dependency units
(HDUs), which serve as both ‘step-up’ and ‘step-down’
areas for patients developing or recovering from critical
illness, respectively.9 These units offer continuous
vital sign monitoring (viz. pulse oximetry and electrocar-
diogram) and a higher nurse-to-patient ratio than that of
the general ward, but do not offer mechanical
ventilation.
The data used for analysis were taken from an exist-
ing database, which was collected prospectively by data
clerks trained specifically in ICU data abstraction. The
primary outcome of our study was the designation
of brain death in the medical chart by the overseeing
clinical officers. While there is no specific policy in
diagnosing brain death at KCH, all providers include
an assessment of lack of brain stem reflexes and lack of
respiratory effort when pausing the mechanical ventila-
tor. Further investigations such as arterial blood
gas analysis and/or advanced imaging are not available
at this central referral hospital nor at any district
hospitals, consistent with most other hospitals in the
region.
The only inclusion criterion was the designation of a
brain death diagnosis in the medical chart by the over-
seeing clinical officer, at any time during the course of
ICU stay. The designation and record of brain death
varied because brain death does not exist as a legal
entity in Malawi. ICU staffing experience varies: not-
ably, some staff check for brain death daily while others
do not. Some staff record their examinations in the
medical chart while others do not. Furthermore, exact
times are not recorded for diagnoses in the medical
chart at this study hospital and this information was
not available.
We excluded ICU readmissions from analysis to
avoid double-counting patients with brain death who
may have been discharged from the ICU and readmitted
from various hospital areas. Clinical data points col-
lected included date of hospital admission, location
before ICU admission (e.g. emergency room, operating
theatre), vital signs and laboratory measurements (e.g.
serum sodium, platelets) at admission to ICU, treat-
ments utilised during the ICU stay (e.g. mechanical ven-
tilation, tracheostomy, CT scanning), human
immunodeficiency virus serostatus, malaria point-of-
care testing, the hospital location to which patients
were discharged, the length of stay in the ICU (in calen-
dar days), and the date of hospital discharge or death.
Figure 1. Map of Malawi with notation for study site, Kamuzu Central Hospital (KCH).
We described the patients diagnosed with brain death
and compared clinical characteristics between these
patients and those without a brain death diagnosis.
Continuous variables were described using the
median and interquartile range (IQR) and categorical
variables using the frequency and percentage, unless
otherwise noted. To compare patients with and without
brain death, we used the 2 test for categorical variables
and Student’s t-test for continuous variables. Statistical
significance was set at P< 0.05 for all analyses, which
were conducted using Stata/SE 14.2 (StataCorps,
College Station, TX, USA). Ethical approval for the
study was provided by the National Health Sciences
Research Council of Malawi and the Institutional
Review Boards of Columbia University and the
University of North Carolina at Chapel Hill.
Results
During the study period, 456 patients were admitted to
the study ICU and, after excluding readmissions, there
were 449 patients included in the analysis. Of these, 43
(9.6%) were diagnosed with brain death during ICU
admission. The timing of this diagnosis was unavail-
able. Demographic data are shown in Table 1.
Among patients who were diagnosed with brain
death at some point during their ICU stay, the most
common reason for ICU admission was trauma (49%)
Table 1. Clinical characteristics and outcomes for patients admitted to the ICU of Kamuzu Central Hospital in Lilongwe, Malawi,




(n¼ 406) P value
Male (n (%)) 27 (64) 178 (44) 0.018
Age (median (IQR)) 29 (18–40) 27 (19–38) 0.488
Admission secondary to trauma (n (%)) 21 (49) 96 (24) <0.001
Location before ICU admission (n (%)) <0.001
Operating theatre 8 (19) 186 (47)
HDU 11 (26) 97 (25)
Ward 6 (14) 38 (10)
Emergency Room 17 (40) 59 (15)
Outside hospital 1 (2) 12 (3)
Vital signs at ICU admission
Heart rate (bpm) (median (IQR)) 119 (94–131) 120 (102–141) 0.229
Mean arterial pressure (mmHg) (median (IQR)) 85 (65–104) 87 (71–103) 0.229
Temperature (C) (median (IQR)) 36 (35–37) 36 (34–37) 0.824
Oxygen saturation (median (IQR)) 98 (95–100) 97 (92–99) 0.803
CT scan of the head performed before ICU admission (n (%)) 7 (16) 40 (10) 0.191
CT scan of the head during ICU stay (n (%)) 4 (9) 23 (6) 0.340
Laboratory values at ICU admission
Platelet count (cells 109/ L) (median (IQR)) 130 (72–191) 154 (99–255) 0.094
Sodium (mEq/L)* (median (IQR)) 143 (139–149) 143 (139–147) 0.436
Creatinine (mmol/L) (median (IQR)) 91.9 (58.3–210.4) 90.2 (58.3–216.6) 0.370
HIV status (positive) (median (IQR)) 5 (15) 34 (10) 0.449
Malaria status (positive) (median (IQR)) 11 (28) 44 (15) 0.030
Provision of mechanical ventilation (n (%)) 43 (100) 390 (97) 0.232
Days of mechanical ventilation (median (IQR)) 3 (2–8) 2 (1–5) 0.863
Provision of tracheostomy (n (%)) 6 (14) 46 (12) 0.639
Time to tracheostomy (days) (median (IQR)) 8 (0–12) 10 (7–13) 0.226
ICU length of stay (days) (median (IQR)) 3 (2–8) 3 (1–5) 0.796
Hospital length of stay (days) (median (IQR)) 5 (3–8) 8 (3–17) 0.007
Hospital mortality (n (%)) 43 (100) 219 (57) <0.001
*Milliequivalents per litre.
followed by malaria (16%) and postoperative monitor-
ing after general abdominal surgery because of undif-
ferentiated intraoperative complications (19%).
(Table 2) Clinical details are shown in Table 1. All
patients diagnosed with brain death were ultimately
declared dead in the hospital, subsequent to cardiac
death.
Discussion
Our study demonstrates that in a critically ill cohort of
African patients in a low-resource setting, 9.6% of
patients were diagnosed with brain death during ICU
stay. This is substantially higher than the incidence rec-
orded in ICUs in high-income settings.10,11 All the
patients diagnosed with brain death remained in the
ICU or a HDU until cardiac death. There is thus no
recognition of brain death as clinical death in Malawi.
These data highlight the need to investigate more thor-
oughly the incidence of brain death and understand the
treatment options of this patient population in a low-
income African setting.
A multitude of studies describe a striking variation in
the application of evidence-based guidelines for the diag-
nosis of brain death.3,6,12 While international standard-
isation of clinical criteria to diagnose brain death has
been advocated as a solution for developing healthcare
systems,12 sociocultural resistance to this concept is rele-
vant and must be taken into account in order to develop
realistic strategies to improving healthcare utilisation. In
the context of ICUmedicine, the ethical imperative to do
no harm is weighed daily against the need to do the most
good for the population at large. Healthcare rationing is
perhaps never as difficult as it is in the assessment of the
critically ill, when the timing of interventions may sig-
nificantly impact outcomes. In general, ICU care should
logically be reserved for those who are most likely to
benefit. Patients who are ‘too well’ should not be
admitted to ICU care, nor should those who are ‘too
sick’ to benefit. A recent medical editorial from
Malawi emphasised this ethical imperative.13 Patients
diagnosed with brain death clearly fall into the ‘too
sick’ category; yet they account for a sizeable proportion
of the ICU population in this study. Addressing this
ethical conundrum requires broad input from the popu-
lace, government leaders, healthcare experts, cultural
and religious leaders, and ethicists.
One possible way to address the sociocultural con-
cerns or discomfort regarding brain death may be to
reframe the concept, from brain death to irreversible
brain failure. This is not just semantics. In critical
care, clinicians frequently discuss organ failure.
Moving away from the word ‘death’ may encourage
clinicians to perform neurologic examinations to
assess brain failure and also help them appreciate that
brain failure is an end-stage consequence of brain
injury (an all too common entity in LICs). While
some organs may be supported by pharmacotherapy
or mechanical devices, the ability to support the brain
in any setting is limited. Performing a neurologic exam-
ination to assess for brain failure may appear quite dif-
ferent to clinicians than performing an examination to
confirm brain death. After ascertaining that a patient
meets criteria for brain failure, clinicians may feel more
comfortable prognosticating with certainty and con-
ducting family discussions. In order to test the effect-
iveness of this suggested change in nomenclature on the
rates of brain death diagnosis and accompanying ICU
utilisation, follow-up studies are required. These studies
should investigate the qualitative effects of this nomen-
clature change on staff and family perceptions of brain
death and the quantitative effects of this nomenclature
on the detection of brain death and ICU utilisation.
Even though brain death is not necessarily recognised
as clinical death at our study hospital in Malawi, the
record of this diagnosis in the patient chart remains not-
able. This implies that overseeing clinicians have a con-
ceptual acceptance of this diagnosis, recognise signs of
brain death and value this diagnosis enough to record it.
The transition from diagnosing and recording brain
death to acting on it (e.g. withdrawing care) may be
more nuanced in certain regions of the world than
others.14 However, the withdrawal of resources from
patients with brain death may allow the hospital to
care for other patients with a better chance of recovery.
It is on this trade-off that patients, families, and health-
care providers in LICs with low-resource healthcare sys-
tems must reflect. In a recent international survey
designed to assess international variation in brain
death definitions, only 10% of respondents were from
LICs. Respondents from these countries were least likely
to have recent experience in diagnosing brain death or to
report institutional protocols for brain death, but most
likely to have greater experience in rationing available
healthcare.3 Even in a setting where brain death is
Table 2. Reason for ICU admission among patients who were
diagnosed with brain death in the ICU.
Reason for admission n (%)
Head injury 18 (42)
General trauma 3 (7)
Malaria 7 (16)
Meningitis 1 (2)
Respiratory failure 4 (9)
Eclampsia 2 (5)
Postoperative monitoring, bowel surgery 8 (19)
Total 43 (100)
accepted socially and culturally, this different experience
may be seen as disempowering. Reframing brain death
as brain failure could, however, empower clinicians by
providing more familiar terminology, which may also
better equip them in their medical recommendations.
After overcoming sociocultural barriers to the concept
of brain death, the determination of brain death or failure
will remain challenging in LICs because of limitations in
diagnostic technology, particularly the lack of imaging
equipment and arterial blood gas analysers to conduct
apnoea tests. Recognition of this reality should not pre-
clude quality research in this arena; rather, it should high-
light the need for a consensus definition of brain death
that is feasible to apply in low-resource environments.
The severity of this situation in Malawi is evidenced by
the fact that only a small proportion of patients with
brain death received a CT scan of the head during their
hospital stay. Our proposal to reframe this concept is not
meant to oversimplify these challenges, but rather to pro-
vide a new way in which to approach them.
Our study has several limitations. First, the study
hospital has no formal criteria for the diagnosis of
brain death. Therefore, it is unlikely that patients
with documented brain death meet a single set of cri-
teria. Second, because this was a secondary analysis of
an existing dataset, we were unable to validate the diag-
nosis of brain death, or to precisely monitor individual
clinicians’ brain death examinations, or to capture the
timing of brain death within the hospital stay. Finally,
the scarcity of ICU beds in this low-resource hospital
means that many patients in need of ICU or HDU care
cannot access it. For this reason, we may not have
captured all critically ill patients at risk of brain
death. Considering these limitations, our reported
prevalence of brain death among critically ill patients
in Malawi is approximate but probably an underesti-
mate, though more precise investigations are needed.
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